KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $968.1 million.

  • Cme's Cash from Operations fell 347.96% to $968.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 billion, marking a year-over-year increase of 1195.08%. This contributed to the annual value of $3.7 billion for FY2024, which is 685.33% up from last year.
  • Per Cme's latest filing, its Cash from Operations stood at $968.1 million for Q3 2025, which was down 347.96% from $1.1 billion recorded in Q2 2025.
  • In the past 5 years, Cme's Cash from Operations registered a high of $1.1 billion during Q1 2025, and its lowest value of $499.8 million during Q2 2021.
  • Over the past 5 years, Cme's median Cash from Operations value was $856.7 million (recorded in 2023), while the average stood at $828.7 million.
  • Examining YoY changes over the last 5 years, Cme's Cash from Operations showed a top increase of 10282.59% in 2021 and a maximum decrease of 4935.14% in 2021.
  • Cme's Cash from Operations (Quarter) stood at $668.3 million in 2021, then surged by 46.87% to $981.5 million in 2022, then increased by 6.4% to $1.0 billion in 2023, then decreased by 2.53% to $1.0 billion in 2024, then decreased by 4.89% to $968.1 million in 2025.
  • Its Cash from Operations stands at $968.1 million for Q3 2025, versus $1.1 billion for Q2 2025 and $1.1 billion for Q1 2025.